Sio Gene Therapies Inc. (SIOX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 49.05M |
| Enterprise Value | -12.16M |
| P/E Ratio | -0.49 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.58 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.86 |
| Fiscal Year | March 31, 2022 |
| Most Recent Quarter | December 31, 2022 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.96 |
| Return On Equity | -0.78 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -70.94M |
| Net Income | -71.89M |
| Diluted EPS | -0.98 |
| Total Cash | 46.13M |
| Total Cash/Share | 0.87 |
| Total Debt | 0 |
| Total Debt/Equity | 0.04 |
| Current Ratio | 5.52 |
| Book Value Per Share | 0.82 |
| 52-Week Change | 16.59 |
| 52-Week High | 0.5 |
| 52-Week Low | 0.25 |
| Moving Average 50 Days | 0.39 |
| Moving Average 200 Days | 0.39 |
| Average Volume | 62,408 |
| Shares Outstanding | 0 |
| % Held by Institutions | 0.09 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:8 |
| Last Split Date | May 08, 2019 |